Neon drop · Free ship $75+ · Enter the grid
Signal · Product Feed

AGN 194310 I-3 A phase I study of

SKU: 87886593237

4.2
USD105.00 USD137.00

Pay in 4 interest-free payments of $26.25 Learn more

Shipping Estimate
USA
  • USA
  • CAN

Ships within 48 hours · Estimated delivery Aug 7 - Aug 12

Live Spec

AGN 194310 I-3 A phase I study ofAGN 194310, also known as VTP 194310, is a pan antagonist of retinoic acid receptors (RARs) with Kd values of 3nM, 2nM and 5nM for RAR , RAR and RAR, respectively. AGN 194310 has been reported to bind to RARs with equal and high Kd values of 3, 2 and 5nM for RAR , RAR and RAR, respectively, by in vitro binding experiments. In addition, AGN 194310 has been revealed to potently inhibit the colony formation by ITS+ grown cell lines with IC50 values of 16

Store: juliusking.com · Domain: juliusking.com

Description

A phase I study of tasisulam sodium (LY573636 sodium)

avian coronavirus

which are not observed in PI3Kδ mutant (p110δD910A) cells

It up regulates PDX1 expression in both primary human islets and ductal cells

PHA-793887 has promising therapeutic activity against acute leukemias in vitro and in vivo

AGN 194310 I-3 A phase I study ofAGN 194310, also known as VTP 194310, is a pan antagonist of retinoic acid receptors (RARs) with Kd values of 3nM, 2nM and 5nM for RAR , RAR and RAR, respectively. AGN 194310 has been reported to bind to RARs with equal and high Kd values of 3, 2 and 5nM for RAR , RAR and RAR, respectively, by in vitro binding experiments. In addition, AGN 194310 has been revealed to potently inhibit the colony formation by ITS+ grown cell lines with IC50 values of 16

Exchange/Return Notes
  • We offer a 30-day return/exchange service after receiving.
  • Final sale items are not eligible for returns or exchanges.
  • To process your return/exchange, please contact us at [email protected]
  • Please click here for more details>>> Return & Exchange Policy

You may also like

recommand products